IMMUNE THERAPEUTICS
At Immune Therapeutics (formerly known as TNI BioTech, Inc.), their goal is to benefit patients with chronic and often life-threatening diseases through the activation and rebalancing of the body's immune system using our patented immunotherapy. Their products, technologies, and patents are designed to harness the power of the immune system to improve the treatment of cancer and infections, such as HIV/AIDS and autoimmune diseases. We are currently developing active and adoptive forms of immunotherapy. Immune Therapeutics' most advanced clinical programs involve immunotherapy with methionine-enkephalin (MENK) or low-dose naltrexone, which both work by triggering opioid receptors on immune cells and lead to the activation and expansion of various cells in the immune system.
IMMUNE THERAPEUTICS
Industry:
Biotechnology Health Care Medical
Founded:
1993-12-02
Address:
Bethesda, Maryland, United States
Country:
United States
Website Url:
http://www.immunetherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
(888) 613-8802
Email Addresses:
[email protected]
Total Funding:
2.89 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt WordPress Google Universal Analytics Font Awesome
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2019-12-16 | Aletheia Therapeutics | Aletheia Therapeutics acquired by Immune Therapeutics | N/A |
Key Employee Changes
Date | New article |
---|---|
2022-08-04 | Immune Therapeutics Appoints Chief Financial Officer and Chief Operating Officer |
2022-07-22 | Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer |
Official Site Inspections
http://www.immunetherapeutics.com
- Host name: 208.91.197.195
- IP address: 208.91.197.195
- Location: British Virgin Islands
- Latitude: 18.5
- Longitude: -64.5
- Timezone: America/Tortola